Home / Solutions / Peripheral Intervention / Stellarex U.S.

StellarexTM drug-coated balloon, featuring EnduraCoatTM Technology, provides top-tier patency to treat common-to-complex lesions with a low drug dose. Low clinically driven target lesion revascularization rates demonstrate the safety of Stellarex across all patients. Only Stellarex offers a critical balance of hybrid paclitaxel and durable excipient to provide efficient drug transfer and effective residency with high coating durability and minimal particulate loss. (download PDF brochure)

Instructions for Use >

Contact Sales Rep Go To Microsite